-
-
-
-
-
-
-
Tempest Therapeutics (TPST) Misses Q3 EPS by 79c
-
-
-
-
-
-
-
Tempest Therapeutics, Inc. (TPST) Misses Q1 EPS by 290c
-
-
-
-
-
-
-
Tempest Therapeutics (TPST) Receives FDA Orphan Drug Designation for Amezalpat
-
-
-
-
-
-
-
Tempest Therapeutics (TPST) Appoints Troy M. Wagner as VP of Quality Assurance
-
-
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

